Come up with a name for your new list and we'll add to it:
Oculis raised a round of funding on December 20, 2016. Investors include
Technology Development Fund.
Oculis is a clinical stage biotechnology company focused on the development of novel and transformative topical treatments (eye drops) for ophthalmic diseases for both back and front of the eye.…